These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36693379)

  • 1. Higher-order SPOP assembly reveals a basis for cancer mutant dysregulation.
    Cuneo MJ; O'Flynn BG; Lo YH; Sabri N; Mittag T
    Mol Cell; 2023 Mar; 83(5):731-745.e4. PubMed ID: 36693379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of oligomer size modulates the competition between cluster formation and phase separation of the tumor suppressor SPOP.
    Sabri N; Cuneo MJ; Marzahn MR; Lee J; Bouchard JJ; Güllülü Ö; Vaithiyalingam S; Borgia MB; Schmit J; Mittag T
    J Biol Chem; 2023 Dec; 299(12):105427. PubMed ID: 37926283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opposing effects of cancer-type-specific SPOP mutants on BET protein degradation and sensitivity to BET inhibitors.
    Janouskova H; El Tekle G; Bellini E; Udeshi ND; Rinaldi A; Ulbricht A; Bernasocchi T; Civenni G; Losa M; Svinkina T; Bielski CM; Kryukov GV; Cascione L; Napoli S; Enchev RI; Mutch DG; Carney ME; Berchuck A; Winterhoff BJN; Broaddus RR; Schraml P; Moch H; Bertoni F; Catapano CV; Peter M; Carr SA; Garraway LA; Wild PJ; Theurillat JP
    Nat Med; 2017 Sep; 23(9):1046-1054. PubMed ID: 28805821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Destruction of DDIT3/CHOP protein by wild-type SPOP but not prostate cancer-associated mutants.
    Zhang P; Gao K; Tang Y; Jin X; An J; Yu H; Wang H; Zhang Y; Wang D; Huang H; Yu L; Wang C
    Hum Mutat; 2014 Sep; 35(9):1142-51. PubMed ID: 24990631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ubiquitin ligase adaptor SPOP in cancer.
    Cuneo MJ; Mittag T
    FEBS J; 2019 Oct; 286(20):3946-3958. PubMed ID: 31495053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposing Roles of
    Cavalcante L; Deshmukh SK; Ribeiro JR; Carneiro BA; Dizon DS; Angara K; Mattox T; Wu S; Xiu J; Walker P; Oberley M; Nabhan C; Huang H; Antonarakis ES
    JCO Precis Oncol; 2023 Sep; 7():e2300088. PubMed ID: 37677121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The emerging role of speckle-type POZ protein (SPOP) in cancer development.
    Mani RS
    Drug Discov Today; 2014 Sep; 19(9):1498-502. PubMed ID: 25058385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer Mutations of the Tumor Suppressor SPOP Disrupt the Formation of Active, Phase-Separated Compartments.
    Bouchard JJ; Otero JH; Scott DC; Szulc E; Martin EW; Sabri N; Granata D; Marzahn MR; Lindorff-Larsen K; Salvatella X; Schulman BA; Mittag T
    Mol Cell; 2018 Oct; 72(1):19-36.e8. PubMed ID: 30244836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulation of INF2-mediated mitochondrial fission in SPOP-mutated prostate cancer.
    Jin X; Wang J; Gao K; Zhang P; Yao L; Tang Y; Tang L; Ma J; Xiao J; Zhang E; Zhu J; Zhang B; Zhao SM; Li Y; Ren S; Huang H; Yu L; Wang C
    PLoS Genet; 2017 Apr; 13(4):e1006748. PubMed ID: 28448495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnover.
    Geng C; He B; Xu L; Barbieri CE; Eedunuri VK; Chew SA; Zimmermann M; Bond R; Shou J; Li C; Blattner M; Lonard DM; Demichelis F; Coarfa C; Rubin MA; Zhou P; O'Malley BW; Mitsiades N
    Proc Natl Acad Sci U S A; 2013 Apr; 110(17):6997-7002. PubMed ID: 23559371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate Cancer-associated SPOP mutations enhance cancer cell survival and docetaxel resistance by upregulating Caprin1-dependent stress granule assembly.
    Shi Q; Zhu Y; Ma J; Chang K; Ding D; Bai Y; Gao K; Zhang P; Mo R; Feng K; Zhao X; Zhang L; Sun H; Jiao D; Chen Y; Sun Y; Zhao SM; Huang H; Li Y; Ren S; Wang C
    Mol Cancer; 2019 Nov; 18(1):170. PubMed ID: 31771591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of oligomer size modulates the competition between cluster formation and phase separation of the tumor suppressor SPOP.
    Sabri N; Cuneo MJ; Marzahn MR; Lee J; Bouchard JJ; Vaithiyalingam S; Borgia MB; Schmit J; Mittag T
    bioRxiv; 2023 Mar; ():. PubMed ID: 36993550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural Insights into BET Client Recognition of Endometrial and Prostate Cancer-Associated SPOP Mutants.
    Ostertag MS; Hutwelker W; Plettenburg O; Sattler M; Popowicz GM
    J Mol Biol; 2019 May; 431(11):2213-2221. PubMed ID: 31026449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deregulation of SPOP in Cancer.
    Zhang H; Jin X; Huang H
    Cancer Res; 2023 Feb; 83(4):489-499. PubMed ID: 36512624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endometrial cancer-associated mutants of SPOP are defective in regulating estrogen receptor-α protein turnover.
    Zhang P; Gao K; Jin X; Ma J; Peng J; Wumaier R; Tang Y; Zhang Y; An J; Yan Q; Dong Y; Huang H; Yu L; Wang C
    Cell Death Dis; 2015 Mar; 6(3):e1687. PubMed ID: 25766326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT-mTORC1 activation.
    Zhang P; Wang D; Zhao Y; Ren S; Gao K; Ye Z; Wang S; Pan CW; Zhu Y; Yan Y; Yang Y; Wu D; He Y; Zhang J; Lu D; Liu X; Yu L; Zhao S; Li Y; Lin D; Wang Y; Wang L; Chen Y; Sun Y; Wang C; Huang H
    Nat Med; 2017 Sep; 23(9):1055-1062. PubMed ID: 28805822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Roles of SPOP in DNA Damage Response and DNA Replication.
    Maekawa M; Higashiyama S
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33023230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher-order oligomerization promotes localization of SPOP to liquid nuclear speckles.
    Marzahn MR; Marada S; Lee J; Nourse A; Kenrick S; Zhao H; Ben-Nissan G; Kolaitis RM; Peters JL; Pounds S; Errington WJ; Privé GG; Taylor JP; Sharon M; Schuck P; Ogden SK; Mittag T
    EMBO J; 2016 Jun; 35(12):1254-75. PubMed ID: 27220849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SPOP promotes ATF2 ubiquitination and degradation to suppress prostate cancer progression.
    Ma J; Chang K; Peng J; Shi Q; Gan H; Gao K; Feng K; Xu F; Zhang H; Dai B; Zhu Y; Shi G; Shen Y; Zhu Y; Qin X; Li Y; Zhang P; Ye D; Wang C
    J Exp Clin Cancer Res; 2018 Jul; 37(1):145. PubMed ID: 29996942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of mutant SPOP proteins in prostate cancer using mass spectrometry-based targeted proteomics.
    Wang H; Barbieri CE; He J; Gao Y; Shi T; Wu C; Schepmoes AA; Fillmore TL; Chae SS; Huang D; Mosquera JM; Qian WJ; Smith RD; Srivastava S; Kagan J; Camp DG; Rodland KD; Rubin MA; Liu T
    J Transl Med; 2017 Aug; 15(1):175. PubMed ID: 28810879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.